CombiMatrix receives approval from NY State to market miscarriage analysis test

CombiMatrix announced that its chromosomal microarray analysis test for miscarriage analysis has received conditional approval from the New York State's Department of Health for testing on patient samples from the state. The company's CMA test for miscarriage analysis, also called a Product of Conception test, is currently CombiMatrix's fastest growing test in terms of volumes.

View Comments (0)